Millennium Management »

Sensei Biotherapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Sensei Biotherapeutics (SNSE) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.6M 147k 31.52

More positions owned by Millennium Management

Astrazeneca Ord Put Option (AZN)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple Put Option (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon Call Option (AMZN)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Tesla Motors Call Option (TSLA)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Select Sector Spdr Tr State Street Fin Put Option (XLF)
Broadcom (AVGO)
Select Sector Spdr Tr State Street Ene Call Option (XLE)

View all positions for Millennium Management

Top funds holding Sensei Biotherapeutics

Vivo Capital
Cormorant Asset Management
Millennium Management
Franklin Resources
Stempoint Capital
Trails Edge Capital Partners
Goldman Sachs Group
Hrt Financial
Suvretta Capital Management
Bank of America Corporation
Logos Global Management
Boothbay Fund Management
Brevan Howard Capital Management
Fred Alger Management
Balyasny Asset Management

View all funds holding Sensei Biotherapeutics